Strategy for enhancement of anti-tumor agents' effects on hemopoietic malignancies.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008875:Middle Aged
D000970:Antineoplastic Agents